Description
Book SynopsisThis edited volume presents seven chapters detailing recent progress in the field of cancer research. Chapter One explores the application of robotic surgery to radical cystectomy, highlighting patient selection, surgical approach, perioperative and oncologic outcomes as well as some areas of controversy in the literature. Chapter Two describes the principles of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures with its potential risks for patients and staff. Chapter Three discusses findings related to ISG15 and protein ISGylation, and their association with interferon signaling in cancer. Chapter Four describes the potential for MCF-7 cells to curb or counteract breast cancer. Chapter Five discusses the potential of emerging technologies in breast conserving treatment. Chapter Six reviews the current literature surrounding the basis of employing the immune system for the treatment of the various non-melanoma skin cancers (NMSC), discusses approved immunotherapies for each type of NMSC as well as indications for use, and synthesizes ongoing investigational studies of immunomodulatory agents for these diseases. Finally, Chapter Seven discusses the use of gene therapy in management of squamous cell carcinoma.
Table of ContentsPreface; Robotic Radical Cystectomy: A Review of Techniques, Outcomes, and Controversies; Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy: Procedures, Potential Risks and Outcomes; ISG15: An Interferon-Stimulated Gene with Critical Functional Implications in Cancer; MCF 7 Cells A Model towards Breakthrough in Breast Cancer Therapy; Progress in Breast Conserving Treatment: Margin Assessment, Irradiation, Ablation; Immunotherapies in Non-Melanoma Skin Cancers; Squamous Cell Carcinoma: Etiology and Advances in the Strategic Management; Index.
